(DBAW) MSCI All World ex U.S. - Overview
Etf: Equities, Hedged-Currency, International, Developed-Emerging
Dividends
| Dividend Yield | 4.13% |
| Yield on Cost 5y | 6.21% |
| Yield CAGR 5y | 22.91% |
| Payout Consistency | 77.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.1% |
| Relative Tail Risk | 0.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.49 |
| Alpha | 17.32 |
| Character TTM | |
|---|---|
| Beta | 0.699 |
| Beta Downside | 0.793 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.11% |
| CAGR/Max DD | 1.34 |
Description: DBAW MSCI All World ex U.S. January 02, 2026
The Xtrackers MSCI All World ex U.S. Hedged Equity ETF (DBAW) follows a passive indexing strategy that aims to mirror the performance of an underlying index covering equity securities in both developed and emerging markets, while employing a currency-hedge to neutralize USD-to-local-currency fluctuations. At least 80 % of the fund’s assets are invested in the index’s constituent stocks, and the ETF is classified as non-diversified under regulatory rules.
Key quantitative points (as of the latest reporting period):
• Expense ratio: 0.30 % (annual), which is competitive for a globally diversified, currency-hedged product.
• Assets under management (AUM): roughly USD 3.2 billion, indicating solid investor interest despite the niche ex-U.S. focus.
• Top sector exposures: Information Technology (~22 %), Financials (~18 %), and Consumer Discretionary (~15 %).
• Currency-hedge impact: Historically, the hedge has reduced portfolio volatility by about 0.8 % annualized and contributed roughly +0.3 % to returns in periods of USD strength.
If you want a data-driven deep-dive on DBAW’s risk-adjusted performance and scenario analysis, consider checking out ValueRay’s analytical tools.
What is the price of DBAW shares?
Over the past week, the price has changed by +2.37%, over one month by +3.59%, over three months by +9.76% and over the past year by +28.86%.
Is DBAW a buy, sell or hold?
What are the forecasts/targets for the DBAW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 54 | 22.7% |
DBAW Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 231.8m USD (231.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 231.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 231.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.49% (E(231.8m)/V(231.8m) * Re(8.49%) + (debt-free company))
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)